Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus
NCT07400952
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Keratoconus
Interventions
DRUG:
GLK-221 Ophthalmic Solution
DRUG:
Placebo Ophthalmic Solution
Sponsor
Glaukos Corporation